Literature DB >> 19205071

A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.

Michelle K Demos1, Vincenzo Macri, Kevin Farrell, Tanya N Nelson, Kristine Chapman, Eric Accili, Linlea Armstrong.   

Abstract

Episodic Ataxia Type 1 is an autosomal dominant disorder characterized by episodes of ataxia and myokymia. It is associated with mutations in the KCNA1 voltage-gated potassium channel gene. In the present study, we describe a family with novel clinical features including persistent cerebellar dysfunction, cerebellar atrophy, and cognitive delay. All affected family members have myokymia and epilepsy, but only one individual has episodes of vertigo. Additional features include postural abnormalities, episodic stiffness and weakness. A novel KCNA1 mutation (c.1222G>T) which replaces a highly conserved valine with leucine at position 408 (p.Val408Leu) was identified in affected family members, and was found to augment the ability of the channel to inactivate. Together, our data suggests that KCNA1 mutations are associated with a broader clinical phenotype, which may include persistent cerebellar dysfunction and cognitive delay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205071     DOI: 10.1002/mds.22467

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  Transcompartmental reversal of single fibre hyperexcitability in juxtaparanodal Kv1.1-deficient vagus nerve axons by activation of nodal KCNQ channels.

Authors:  Edward Glasscock; Jing Qian; Matthew J Kole; Jeffrey L Noebels
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

2.  A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia.

Authors:  Karine Choquet; Roberta La Piana; Bernard Brais
Journal:  Neurogenetics       Date:  2015-01-08       Impact factor: 2.660

Review 3.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

4.  Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).

Authors:  Vikas Mishra; Bharat K Karumuri; Nicole M Gautier; Rui Liu; Timothy N Hutson; Stephanie L Vanhoof-Villalba; Ioannis Vlachos; Leonidas Iasemidis; Edward Glasscock
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

5.  Mechanism of accelerated current decay caused by an episodic ataxia type-1-associated mutant in a potassium channel pore.

Authors:  Christian J Peters; Daniel Werry; Hira S Gill; Eric A Accili; David Fedida
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

6.  Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Authors:  Pawel Tacik; Kimberly J Guthrie; Audrey J Strongosky; Daniel F Broderick; Douglas L Riegert-Johnson; Sha Tang; Dima El-Khechen; Alexander S Parker; Owen A Ross; Zbigniew K Wszolek
Journal:  Mayo Clin Proc       Date:  2015-02-03       Impact factor: 7.616

Review 7.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

8.  Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.

Authors:  Barbara Fellerhoff-Losch; Sergiy V Korol; Yonatan Ganor; Songhai Gu; Itzik Cooper; Raya Eilam; Michal Besser; Meidan Goldfinger; Yehuda Chowers; Rudolf Wank; Bryndis Birnir; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2015-11-26       Impact factor: 3.575

9.  Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2020-03-26       Impact factor: 4.030

Review 10.  Genomic biomarkers of SUDEP in brain and heart.

Authors:  Edward Glasscock
Journal:  Epilepsy Behav       Date:  2013-10-17       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.